// App-Quantinova.ai

TAMI-76 : INTEGRATED MULTI-OMICS REVEAL INTRATUMOUR HETEROGENEITY AND NOVEL THERAPEUTIC TARGETS IN PAEDIATRIC EPENDYMOMA

Researchers

Presenter

  • Alina Pandele

Principal Investigators

  • Alison Woodward

  • Sophie Lankford

  • Donald Macarthur

  • Ian Kamaly-Asl

  • David Barrett

  • Richard Grundy

  • Dong-Hyun Kim

  • Ruman Rahman

Medical Centers

  • Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham, UK

  • Centre for Analytical Bioscience, Advanced Materials and Healthcare Technologies, School of Pharmacy, The University of Nottingham, Nottingham, UK

  • Children's Brain Tumour Research Centre, School of Medicine, The University of Nottingham, Biodiscovery Institute, Nottingham, UK

  • Royal Manchester Children’s Hospital, Manchester, UK

  • Department of Neurosurgery, Nottingham University Hospitals NHS Trust, Nottingham, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Oncology (ONC)

Disease

  • Cerebral metastases

  • Ependymoma

Biomarkers

  • Aldehyde Dehydrogenase 3 Family Member A1

  • 5'-nucleotidase

  • RELA

Drug/Treatment

  • Tamsulosin Hydrochloride

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A